FindTrial
Sign In

A Clinical Study for Serum sTNFR and Dectin Receptors Levels detected separately and jointly in Ischemic Stroke

A Clinical Study for Serum sTNFR and Dectin Receptors Levels detected separately and jointly in Ischemic Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020189
Enrollment
Unknown
Registered
2018-12-19
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

Cases group:Nil
Health group:Nil

Sponsors

Changzhou Tumor Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. According to the standard of "China guidelines for the diagnosis and treatment of acute ischemic stroke 2018", it has been confirmed by computed tomography (CT) or magnetic resonance imaging (MRI); 2. First onset, aged 18-80 years old; 3. Collect specimens within 72 hours after onset; 4. Informed consent was given by patients and their families, and informed consent was signed

Exclusion criteria

Exclusion criteria: All subjects were excluded from acute myocardial infarction and other vascular embolic diseases, malignant tumors, autoimmune diseases, severe lung, liver or blood system diseases, severe neurological infections and neurodegenerative diseases, and acute or chronic inflammatory diseases

Design outcomes

Primary

MeasureTime frame
serum sTNFR1/2;serum Dectin1/2;NHISS score;—

Countries

China

Contacts

Public ContactLiu Huiling

Changzhou Tumor Hospital

liuhuiling003@163.com+86 15051978890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026